Effectiveness of Transcatheter Reduction of Significant Mitral Regurgitation in High Surgical Risk Patients with Mitraclip: Final 5 Year Results of the Everest II High Risk Registry (original) (raw)

The EVEREST II High Risk Registry evaluated the effectiveness of the MitraClip procedure in 78 patients with significant mitral regurgitation at high surgical risk over five years. Results showed durable reduction in mitral regurgitation severity, improved left ventricular remodeling, enhanced quality of life, and a significant decrease in re-hospitalizations for congestive heart failure. With a 5-year survival of 44% and 70% of patients maintaining reduced MR, this study underscores the procedure's long-term efficacy in this vulnerable population.